Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DPR000090

Drug Information
NamePD-160170
Synonyms5-nitro-6-(2-propan-2-ylphenyl)sulfonyl-quinolin-8-amine; BRD-K12079898-001-01-8; CHEMBL422942; PD-160170; MolPort-003-983-659; NCGC00092332-01; CID9820766; CHEBI:180003
CompanyParke CDavis
IndicationHypertension. Obesity, Heart disease
[ICD9: 278, 390-429   ICD10: E66, I00-I52]
Preclinical    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H17N3O4S/c1-11(2)12-6-3-4-8-15(12)26(24,25)16-10-14(19)17-1
3(7-5-9-20-17)18(16)21(22)23/h3-11H,19H2,1-2H3
InChIKeyYUVNGBZROXQYQH-UHFFFAOYSA-N
Canonical SMILESCC(C)C1=CC=CC=C1S(=O)(=O)C2=C(C3=C(C(=C2)N)N=CC=C3)[N+](=O)[O-]    
CAS NumberCAS 181468-88-2
PubChem Compound IDCID 9820766.
PubChem Substance IDSID 14779594.
TargetNeuropeptide Y receptor type 1 Antagonist[1]
Ref 1Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543